Compounds > lasofoxifene
Page last updated: 2024-09-05

lasofoxifene and Fracture, Pathologic

lasofoxifene has been researched along with Fracture, Pathologic in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies

Other Studies

1 other study(ies) available for lasofoxifene and Fracture, Pathologic

ArticleYear
Lasofoxifene: new drug. Osteoporosis: no better than raloxifene.
    Prescrire international, 2009, Volume: 18, Issue:104

    Topics: Bone Density; Bone Density Conservation Agents; Diphosphonates; Europe; Female; Fractures, Spontaneous; Humans; Osteoporosis, Postmenopausal; Pyrrolidines; Raloxifene Hydrochloride; Randomized Controlled Trials as Topic; Tetrahydronaphthalenes

2009